Emerging Therapeutics for Pulmonary Arterial Hypertension

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Emerging Therapeutics for Pulmonary Arterial Hypertension

By Cleveland Clinic Hospital Based Care Institute FEATURING Bradley Maron

920 views

April 10, 2023

This webcast series includes repurposed education from Cleveland Clinic's Pulmonary Hypertension Summit 2022. This educational ...
read more ↘ activity will keep clinicians updated on the advances in the diagnosis and treatment of PH. The Activity Director and presenters, all renowned experts in Pulmonary Hypertension, have identified the following topics as having knowledge, competency, and practice gaps among clinicians:

Advances in the diagnostic and hemodynamic evaluation of PH.
Risk stratification and treatment algorithms.
Emerging therapies.
PH in patients with heart failure with preserved ejection fraction.
PH in patients with interstitial lung disease.
Chronic thromboembolic PH.
Pulmonary vascular limitation in patients who survive COVID-19.
Pulmonary hypertension through pulmonary vascular disease phenomics (PVDOMICs).
Heterogeneity of metabolic endo-phenotypes of PAH.
Metabolic interventions in PAH.
PAH single-cell omics atlas.
↖ read less

Comments 0